⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Imprimis NJOF, LLC: Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-5

DrugsSource: FDA (drug) · Date: 2026-01-14

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Imprimis NJOF

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Imprimis NJOF, LLC
Product
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Reason / hazard
Presence of particulate matter - Glass like particles.
Classification
Class II
Status
Ongoing
Distribution / sold at
U.S Nationwide
Recall initiated
2025-12-18
Code info
Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
Product quantity
778 boxes of 15,540 pre-filled syringes
Voluntary mandated
Voluntary: Firm initiated
City
Ledgewood
State
NJ
Country
United States
Event id
98181
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.